If you were on a higher dose (1mg or above), your provider may recommend: - Restarting at your current dose if the gap was exactly 2 weeks - Stepping down one dose level if the gap was 24 weeks - Restarting the full titration from 0.25mg if the gap was more than 4 weeks **Why dose adjustment matters**: Your GI system de-adapts to semaglutide during extended breaks
Can I switch from semaglutide to tirzepatide if semaglutide stops working
The evidentiary structure is a chain of inferences, only as strong as its weakest link: synergy shown for other GHRP+GHRH pairs, extrapolated to this pair
This distinction matters because 503B facilities face stricter FDA oversight, including current Good Manufacturing Practice (cGMP) requirements, than standard 503A pharmacies
This includes heart disease, stroke, type 2 diabetes, some cancers, and even heart attacks
Maybe that should serve as a hint that we need to look into this